RPRX
NASDAQ
US
Royalty Pharma plc - Class A Ordinary Shares
$48.57
▲ +$0.08
(+0.17%)
Vol 2.7M
10
Quality Score
ok
Deep Check
1/5
fail
Rev ✗
NI ✓
>IPO ✗
Mkt Cap
$22.3B
P/E
29.2
ROE
11.6%
Margin
32.6%
D/E
139.46
Beta
0.42
Div Yield
2.28%
52W
$25–$41
Wall Street Consensus
16 analysts · Apr 20265
Strong Buy
9
Buy
2
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $1.35 | $1.47 | +$0.12 |
| Sep 2025 | $1.06 | $1.17 | +$0.11 |
| Jun 2025 | $1.11 | $1.14 | +$0.03 |
| Mar 2025 | $1.62 | $0.65 | $-0.97 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 15.2% | 15.2% | 15.2% | 15.2% | 11.6% | 11.6% |
| P/E (TTM) | 19.85 | 21.00 | 20.78 | 21.45 | 29.83 | 29.16 |
| Net Margin | 5.2% | 44.3% | 44.3% | 44.3% | 32.5% | 32.5% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 126.07 | 126.07 | 126.07 | 126.07 | 139.46 | 139.46 |
| Current Ratio | 1.26 | 1.26 | 1.26 | 1.26 | 3.48 | 3.48 |
Key Ratios
ROA (TTM)
4.2%
P/S (TTM)
9.49
P/B
2.2
EPS (TTM)
$1.33
CF/Share
$0.66
Rev Growth 3Y
-0.4%
52W High
$41.24
52W Low
$25.02
$25.02
52-Week Range
$41.24
How does RPRX compare to Pharmaceuticals peers?
Peer group: Large-cap Pharmaceuticals ($10B+) · 7 companies
RPRX valuation vs Pharmaceuticals peers
P/E ratio
29.2
▲
60%
above
peers
(18.2)
vs Peers
vs Industry
Pricier
P/S ratio
9.5
▲
200%
above
peers
(3.2)
vs Peers
vs Industry
Overvalued
P/B ratio
2.2
▲
9%
above
peers
(2.0)
vs Peers
vs Industry
Fair value
Div yield
2.3%
▼
26%
below
peers
(3.1%)
vs Peers
vs Industry
Low yield
RPRX profitability vs Pharmaceuticals peers
ROE
11.6%
▲
0%
above
peers
(11.6%)
vs Peers
vs Industry
In line
Net margin
32.6%
▲
77%
above
peers
(18.4%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼
0%
below
peers
(72.3%)
vs Peers
vs Industry
Top tier
ROA
4.2%
▲
0%
above
peers
(4.2%)
vs Peers
vs Industry
In line
RPRX financial health vs Pharmaceuticals peers
D/E ratio
139.5
▲
96%
above
peers
(71.1)
vs Peers
vs Industry
High debt
Current ratio
3.5
▲
111%
above
peers
(1.7)
vs Peers
vs Industry
Below avg
Beta
0.4
▼
51%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
RPRX fundamentals radar
RPRX
Peer median
Industry
RPRX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
RPRX vs peers: key metrics
Latest News
No related news yet